Engineering herpes simplex viruses by infection-transfection methods including recombination site targeting by CRISPR/Cas9 nucleases

Journal of Virological Methods

Volumn 213, Issue , 2015, Pages 18-25

  Russell, Tiffany A ^a   Stefanovic, Tijana ^a   Tscharke, David C ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

Cas9; CRISPR; Genome engineering; Herpes simplex virus; Recombinant virus

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; BIOENGINEERING; CONTROLLED STUDY; CRISPR CAS SYSTEM; CRISPR CAS9 SYSTEM; FEMALE; GENE FUNCTION; GENE TARGETING; GENETIC TRANSFECTION; HERPES SIMPLEX VIRUS 1 (STRAIN KOS); HOMOLOGOUS RECOMBINATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; VIROGENESIS; VIRUS GENOME; VIRUS VIRULENCE; ANIMAL; C57BL MOUSE; CELL LINE; CHLOROCEBUS AETHIOPS; GENETIC RECOMBINATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; MOLECULAR BIOLOGY; PROCEDURES; SIMPLEXVIRUS; VIRUS REPLICATION;

MAMMALIA; SIMPLEXVIRUS;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; CRISPR-CAS SYSTEMS; GENE TARGETING; HUMANS; MICE, INBRED C57BL; MOLECULAR BIOLOGY; RECOMBINATION, GENETIC; SIMPLEXVIRUS; TRANSFECTION; VIRUS REPLICATION;

EID: 84916912019     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2014.11.009     Document Type: Article

References (34)

1. Balliet J.W., Kushnir A.S., Schaffer P.A. Construction and characterization of a herpes simplex virus type I recombinant expressing green fluorescent protein: acute phase replication and reactivation in mice. Virology 2007, 361:372-383.
2. Bi Y., Sun L., Gao D., Ding C., Li Z., Li Y., Cun W., Li Q. High-efficiency targeted editing of large viral genomes by RNA-guided nucleases. PLoS Pathog. 2014, 10:e1004090.
3. Blyth W.A., Harbour D.A., Hill T.J. Pathogenesis of zosteriform spread of Herpes Simplex virus in the mouse. J. Gen. Virol. 1984, 65:1477-1486.
4. Bradley H., Markowitz L.E., Gibson T., McQuillan G.M. Seroprevalence of Herpes Simplex Virus Types 1 and 2-United States, 1999-2010. J. Infect. Dis. 2014, 209:325-333.
5. Cong L., Ran F.A., Cox D., Lin S., Barretto R., Habib N., Hsu P.D., Wu X., Jiang W., Marraffini L.A., Zhang F. Multiplex genome engineering using CRISPR/Cas systems. Science 2013, 339:819-823.
6. Cunningham A.L., Taylor R., Taylor J., Marks C., Shaw J., Mindel A. Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based survey. Sex Transm. Infect. 2006, 82:164-168.
7. Ding X., Sanchez D.J., Shahangian A., Al-Shyoukh I., Cheng G., Ho C.M. Cascade search for HSV-1 combinatorial drugs with high antiviral efficacy and low toxicity. Int. J. Nanomed. 2012, 7:2281-2292.
8. Gierasch W.W., Zimmerman D.L., Ward S.L., Van Heyningen T.K., Romine J.D., Leib D.A. Construction and characterization of bacterial artificial chromosomes containing HSV-1 strains 17 and KOS. J. Virol. Met. 2006, 135:197-206.
9. Goins W.F., Krisky D.M., Wechuck J.B., Huang S., Glorioso J.C. Construction and production of recombinant herpes simplex virus vectors. Methods Mol. Biol. 2008, 433:97-113.
10. Halford W.P., Balliet J.W., Gebhardt B.M. Re-evaluating natural resistance to herpes simplex virus type 1. J. Virol. 2004, 78:10086-10095.
11. Hogk I., Kaufmann M., Finkelmeier D., Rupp S., Burger-Kentischer A. An in vitro HSV-1 reactivation model containing quiescently infected PC12 cells. Biores. Open Access 2013, 2:250-257.
12. Horsburgh B.C., Hubinette M.M., Qiang D., MacDonald M.L., Tufaro F. Allele replacement: an application that permits rapid manipulation of herpes simplex virus type 1 genomes. Gene Ther. 1999, 6:922-930.
13. Lee E.C., Yu D., Martinez de Velasco J., Tessarollo L., Swing D.A., Court D.L., Jenkins N.A., Copeland N.G. A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 2001, 73:56-65.
14. Leland D.S., Ginocchio C.C. Role of cell culture for virus detection in the age of technology. Clin. Microbiol. Rev. 2007, 20:49-78.
15. + tissue-resident memory T cells of skin. Nat. Immunol. 2013, 14:1294-1301.
16. Mackett M., Smith G.L., Moss B. General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J. Virol. 1984, 49:857-864.
17. + T-cell effector activity during skin infection with HSV-1. PLoS Pathog. 2014, 10:e1004303.
18. Markert J.M., Medlock M.D., Rabkin S.D., Gillespie G.Y., Todo T., Hunter W.D., Palmer C.A., Feigenbaum F., Tornatore C., Tufaro F., Martuza R.L. Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial. Gene Ther. 2000, 7:867-874.
19. Morimoto T., Arii J., Akashi H., Kawaguchi Y. Identification of multiple sites suitable for insertion of foreign genes in herpes simplex virus genomes. Microbiol. Immunol. 2009, 53:155-161.
20. Orr M.T., Edelmann K.H., Vieira J., Corey L., Raulet D.H., Wilson C.B. Inhibition of MHC class I is a virulence factor in herpes simplex virus infection of mice. PLoS Pathog. 2005, 1:62-71.
21. Proenca J.T., Coleman H.M., Connor V., Winton D.J., Efstathiou S. A historical analysis of herpes simplex virus promoter activation in vivo reveals distinct populations of latently infected neurones. J. Gen. Virol. 2008, 89:2965-2974.
22. Ramachandran S., Knickelbein J.E., Ferko C., Hendricks R.L., Kinchington P.R. Development and pathogenic evaluation of recombinant herpes simplex virus type 1 expressing two fluorescent reporter genes from different lytic promoters. Virology 2008, 378:254-264.
23. Rampling R., Cruickshank G., Papanastassiou V., Nicoll J., Hadley D., Brennan D., Petty R., MacLean A., Harland J., McKie E., Mabbs R., Brown M. Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma. Gene Ther. 2000, 7:859-866.
24. Rasband W.S. ImageJ 1997-2012, U.S. National Institutes of Health, Bethesda, MD, USA.
25. Rinaldi A., Marshall K.R., Preston C.M. A non-cytotoxic herpes simplex virus vector which expresses Cre recombinase directs efficient site specific recombination. Virus Res. 1999, 65:11-20.
26. Sawtell N.M., Thompson R.L. Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia. J. Virol. 1992, 66:2150-2156.
27. Shimeld C., Whiteland J.L., Williams N.A., Easty D.L., Hill T.J. Reactivation of herpes simplex virus type 1 in the mouse trigeminal ganglion: an in vivo study of virus antigen and immune cell infiltration. J. Gen. Virol. 1996, 77:2583-2590.
28. Simmons A., Nash A.A. Zosteriform spread of herpes simplex virus as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease. J. Virol. 1984, 52:816-821.
29. Suenaga T., Kohyama M., Hirayasu K., Arase H. Engineering large viral DNA genomes using the CRISPR-Cas9 system. Microbiol. Immunol. 2014, 58:513-522.
30. Summers B.C., Leib D.A. Herpes simplex virus type 1 origins of DNA replication play no role in the regulation of flanking promoters. J. Virol. 2002, 76:7020-7029.
31. Tanaka M., Kagawa H., Yamanashi Y., Sata T., Kawaguchi Y. Construction of an excisable bacterial artificial chromosome containing a full-length infectious clone of herpes simplex virus type 1: viruses reconstituted from the clone exhibit wild-type properties in vitro and in vivo. J. Virol. 2003, 77:1382-1391.
32. Tanaka M., Kodaira H., Nishiyama Y., Sata T., Kawaguchi Y. Construction of recombinant herpes simplex virus type I expressing green fluorescent protein without loss of any viral genes. Microbes Infect. 2004, 6:485-493.
33. + T cells can clear established lytic infections from skin and nerves and can partially limit the early spread of virus after cutaneous inoculation. J. Immunol. 2004, 172:392-397.
34. Wong Y.C., Lin L.C.W., Melo-Silva C.R., Smith S.A., Tscharke D.C. Engineering recombinant poxviruses using a compact GFP-blasticidin resistance fusion gene for selection. J. Virol. Methods 2011, 171:295-298.